Author: Healio ophthalmology

Innovation in ophthalmology pushes forward

SAN FRANCISCO — The future of innovation in ophthalmology is promising, with more forward movement than drag, according to a speaker here. “The tailwinds are stronger than the headwinds,” William J. Link, PhD, managing director of Versant Ventures, told colleagues interested in supporting innovation in the ophthalmic space at the Ophthalmology Innovation Summit.

FDA focus on more efficient processing yields faster decisions

SAN FRANCISCO — The U.S. Food and Drug Administration has been criticized for its ponderous movement of potential drugs and medical devices through the approval process. Recognizing this criticism, and following implementation of the Medical Devices User Fee and Modernization Act of 2002 and subsequent internal reevaluations and reorganizations, the FDA approval process for innovative technologies has been gaining speed since 2010.“We believe the U.S. is and should remain the leading innovation leader,” Malvina B. Eydelman, MD, director of the FDA Division of Ophthalmic and Ear, Nose and Throat Devices, said at the Ophthalmology Innovation Summit meeting here.

Umbilical cord blood serum promotes endothelial healing in severe dry eye

Heterologous umbilical cord blood serum-based eye drops may enable healing of diseased corneal epithelium and reduce symptoms in patients with severe dry eye disease, according to a study.The study included 33 eyes of 17 patients with graft-versus-host disease and 26 eyes of 13 patients with Sjögren’s syndrome. Patients’ mean ages were 38.8 years in the graft-versus-host disease group and 59.6 years in the Sjögren’s syndrome group. All patients received sterile cord blood serum eye drops daily for 1 month.

David Tanzer named chief medical officer of Abbott Medical Optics

Abbott Medical Optics has named David Tanzer, MD, as its divisional vice president of medical affairs and chief medical officer, according to a company news release.In this role, Tanzer will offer medical input for the company’s clinical strategy, innovation and business development activities while overseeing medical affairs and product safety, as well as the development and dissemination of educational materials.

Online medical professionalism statement targets social media use

According to a position paper designed by researchers from the American College of Physicians and the Federation of State Medical Boards, new technologies and practices have pulled patients and physicians into a Web-based relationship. Although popular by nature, this form of communication should be conducted with the utmost professionalism.“It is important for physicians to be aware of the implications for confidentiality and how the use of online media for non-clinical purposes impacts trust in the medical profession,” Humayun Chaudhry, DO, MS, FACP, co-author and president and CEO of the Federation of State Medical Boards, said in a press release.